Prelude Capital Management, LLC Pfizer Inc Put Options Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $23,443 - $26,439	-700 Reduced 0.35%	200,300 $7.26 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $6.7 Million - $8.52 Million	200,100 Added 22233.33%	201,000 $7.4 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $29,241 - $37,917	900 New	900 $32,000
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $1.88 Million - $2.11 Million	-50,900 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $1.91 Million - $2.1 Million	50,900 New	50,900 $2.16 Million

3,220

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.